[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 2294 Introduced in Senate (IS)]

<DOC>






119th CONGRESS
  1st Session
                                S. 2294

     To reauthorize the Kay Hagan Tick Act, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             July 15, 2025

   Ms. Collins (for herself, Ms. Smith, and Mr. King) introduced the 
 following bill; which was read twice and referred to the Committee on 
                 Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
     To reauthorize the Kay Hagan Tick Act, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Kay Hagan Tick Reauthorization 
Act''.

SEC. 2. REAUTHORIZATION OF PROGRAMS.

    (a) National Strategy and Regional Centers of Excellence in Vector-
Borne Disease.--Section 317U of the Public Health Service Act (42 
U.S.C. 247b-23) is amended--
            (1) in subsection (b), in the matter preceding paragraph 
        (1), by striking ``the Tick-Borne Disease Working Group 
        established under section 2062 of the 21st Century Cures Act 
        (42 U.S.C. 284s) and other individuals, as appropriate'' and 
        inserting ``appropriate individuals''; and
            (2) in subsection (f), by striking ``$10,000,000 for each 
        of fiscal years 2021 through 2025'' and inserting ``$8,000,000 
        for each of fiscal years 2026 through 2030''.
    (b) Enhanced Support To Assist Health Departments in Addressing 
Vector-Borne Diseases.--Section 2822(c) of the Public Health Service 
Act (42 U.S.C. 300hh-32(c)) is amended by striking ``$20,000,000 for 
each of fiscal years 2021 through 2025'' and inserting ``$19,000,000 
for each of fiscal years 2026 through 2030''.
                                 <all>